Board of Directors

Galenica’s Board of Directors consists of seven members and has ultimate responsibility for the company and its subsidiaries’ business and affairs. The Board of Directors is composed of highly experienced experts and personalities with decades of industry experience and extensive knowledge about the Galenica business.

Daniela Bosshardt-Hengartner

Daniela Bosshardt-Hengartner
Chairwoman of the Board of Directors

  • Elected since 2017
  • Born 1972, Swiss citizen
  • Pharmacist, Federal Diploma in Pharmacy, Federal Institute of Technology, Zurich
  • Financial analyst at Bank am Bellevue (1998-2002) and M2 Capital (2003-2004)
  • Management consultant in the pharmaceutical, medical technology and biotechnology sectors since 2004
  • Member of the Board of Directors of RepRisk AG (Zurich)
Bertrand Jungo

Bertrand Jungo
Vice-Chairman of the Board of Directors

  • Elected since 2018
  • Born 1965, Swiss citizen
  • Management degree, lic.rer.pol., University of Freiburg
  • From 2006 to 2017 CEO of the department store group Manor, beforehand held various management positions during 10 years at Manor
  • Since 2017 CEO of Admeira Ltd.
  • Advisory Board member of the International Retail Summit (Gottlieb Duttweiler Institute,GDI)
Prof. Dr. Michel Burnier

Prof. Dr. Michel Burnier

  • Elected since 2017
  • Born 1953, Swiss citizen
  • Swiss-registered Doctor of Internal Medicine and Nephrology
  • University Lecturer, University of Lausanne
  • Member of the following organisations: Swiss Society of Nephrology (former President), European Society of Hypertension (council member and Treasurer) and Swiss Society of Hypertension (former President)
  • Formerly a member of the Medicines Committee of the Swiss Association of Pharmacists (until 2001), the Board of Swissmedic (2002-2010)
  • Member of the Board of Directors of Speedel Holding Ltd. (Basel) from 2007 to 2009
  • Member of the Board of Directors of Vifor Pharma Ltd. (Zurich)
Fritz Hirsbrunner

Fritz Hirsbrunner

  • Elected since 2017
  • Born 1949, Swiss citizen
  • Lic. oec., HEC University of Lausanne / Senior Executive Program, IMD, Lausanne
  • 1972–1977 Controller at Ciba-Geigy
  • Joined the former Galenica Group in 1977 as Assistant to the Corporate Executive Committee; member of the Corporate Executive Committee from 1992 to 2011; Deputy CEO and CFO; Head Investor Relations until 2014 Member of the Board of Trustees of IST Investmentstiftung für Personalvorsorge (Zurich)
  • Member of the Board of Directors of Berlac AG (Sissach), IVF Hartmann Holding AG (Neuhausen), VenCap 6 Ltd. (Jersey) and Vifor Pharma Ltd. (Zurich)
Dr. Markus R. Neuhaus

Dr. Markus R. Neuhaus

  • Elected since 2019
  • Born 1958, Swiss citizen
  • Dr. iur., certified tax expert
  • Various roles at PwC from 1985, including CEO of PwC Switzerland from 2003 to 2012, member of PwC's Global Board from 2005 to 2007, member of the PwC Network Executive Team from 2010 to 2013, member of PwC's Office of the Global Chairman from 2013 to 2016 and Chairman of PwC Switzerland from 2012 to 2019
  • Various other functions, including Chairman of the Zürcher Volkswirtschaftlichen Gesellschaft, Vice Chairman of the Zurich Chamber of Commerce, Vice Chairman of Avenir Suisse and Chairman of the Finance and Tax Commission of Economiesuisse
  • Member of the Board of Directors of Barry Callebaut AG, Baloise Holding AG, Orior AG and Jacobs Holding AG
Dr. Philippe Nussbaumer

Dr. Philippe Nussbaumer

  • Elected since 2017
  • Born 1969, Swiss citizen
  • FPH Pharmacist, Federal Diploma / PhD in Pharmaceutical Sciences, University of Geneva / dipl. oec. HEC, University of Lausanne
  • Federal Ski Instructor Diploma and Federal Expert J+S; since 2004, Vice-President of the Swiss Snowsports School of Neuchâtel / Les Bugnenets
  • Owner and president of the Pharmacie Centrale and the Pharmacie de la Gare in La Chaux-de-Fonds
  • Since 2007, founder and administrator of Ecopharma pharmacy brand
  • Since 2014, owner and president of the Medi-Centre Ltd. medical centre in La Chaux-de-Fonds
  • Since 2012, Member of the Board of Directors of Veripharm Ltd.
Dr. Andreas Walde

Dr. Andreas Walde

  • Elected since 2017
  • Born 1962, Swiss citizen
  • Attorney-at-law and doctorate in law, University of Basel
  • Various legal and management positions in the chemical and pharmaceutical industry for more than 25 years: 1988-1996 at Roche, 1998-2010 at Clariant and 2012-2013 at Petroplus, in the latter two notably as group general counsel; General Secretary of Vifor Pharma Ltd. (Zurich), former Galenica Group, since 2013
  • Former positions include memberships on the boards of several private (non-Swiss) public listed companies as well as on the board of the Society of Swiss Enterprises in Germany
  • Member of the Board of SwissHoldings, the Federation of Industrial and Service Groups in Switzerland